Search - tctmd.com

Displaying 1 - 20 of 32

Sort: Relevancy | Date

Side Effects of Statins Might Be Overstated: CTT Collaboration

News Daily News

Side Effects of Statins Might Be Overstated: CTT Collaboration

Michael O'Riordan

February 12, 2026

January 2026 Dispatch for the CV Team

News Opinion CV Team Dispatch

January 2026 Dispatch for the CV Team

January 16, 2026

Volt Pulsed-Field Ablation System Gains FDA Approval

News Daily News

Volt Pulsed-Field Ablation System Gains FDA Approval

December 24, 2025

Etripamil Nasal Spray Gains FDA Approval for Acute Paroxysmal SVT

News Daily News

Etripamil Nasal Spray Gains FDA Approval for Acute Paroxysmal SVT

December 15, 2025

FDA Approves Lerodalcibep for Adults With Hypercholesterolemia

News Daily News

FDA Approves Lerodalcibep for Adults With Hypercholesterolemia

Yael L. Maxwell

December 15, 2025

Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients

News Daily News

Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients

October 22, 2025

Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol

News Daily News

Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol

Michael O'Riordan

August 06, 2025

FDA Approves Finerenone for HF Patients With Mildly Reduced or Preserved EF

News Daily News

FDA Approves Finerenone for HF Patients With Mildly Reduced or Preserved EF

July 14, 2025

June 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

June 01, 2024

Biologic Winrevair Wins FDA Approval for Treatment of PAH

News Daily News

Biologic Winrevair Wins FDA Approval for Treatment of PAH

March 27, 2024

FDA Grants MACE Reduction Indication for Semaglutide

News Daily News

FDA Grants MACE Reduction Indication for Semaglutide

March 08, 2024

TCTMD’s Top 10 Most Popular Stories for December 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2023

December 28, 2023

First Pulsed-Field Ablation System Gets FDA Approval

News Daily News

First Pulsed-Field Ablation System Gets FDA Approval

December 14, 2023

FDA Approves Colchicine for Decreasing CV Events

News Daily News

FDA Approves Colchicine for Decreasing CV Events

June 20, 2023

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

News Features

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Michael O'Riordan

August 15, 2022

British Medical Groups Express Concern About Inclisiran Rollout

News Daily News

British Medical Groups Express Concern About Inclisiran Rollout

Michael O'Riordan

December 14, 2021

FDA Approves Dapagliflozin for CKD Patients

News Daily News

FDA Approves Dapagliflozin for CKD Patients

Michael O'Riordan

May 03, 2021

FDA Approves Harmony TPV for Pulmonary-Valve Regurgitation in Congenital HD

News Daily News

FDA Approves Harmony TPV for Pulmonary-Valve Regurgitation in Congenital HD

Yael L. Maxwell

March 26, 2021

FDA Approves Shockwave Intravascular Lithotripsy for Calcified Coronaries

News Daily News

FDA Approves Shockwave Intravascular Lithotripsy for Calcified Coronaries

February 16, 2021

Inclisiran Approved in Europe for Lowering LDL Cholesterol

News Daily News

Inclisiran Approved in Europe for Lowering LDL Cholesterol

Michael O'Riordan

December 11, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.